LatentVerse
LatentVerse develops foundation models that combine perception, prediction and robot action.
UndisclosedSeed
ParticipantActivity from announced rounds
GL Ventures is the Hillhouse-origin early-stage venture firm identified in LTZ and Clipto issuer announcements.
LTZ develops cancer immunotherapies targeting myeloid biology. Clipto supplies tools for searching video and audio libraries, while Anew combines AI models and experiments for drug discovery. These histories remain distinct from the Hillhouse parent and named funds.
LatentVerse develops foundation models that combine perception, prediction and robot action.